e m b r a c e l i f e
“My face
what wordsexpresses
cannot “
Pure E
legance. Pure B
eauty.
Pure E
legance. Pure B
eauty.
Stylelure’s Advanced Dermal Whitening skin products are all based on a unique scientific discovery
of a naturally occurring bio-active substance, Melanozyme™, which acts to decompose the
melanin in a clinically proven, fast and safe manner with no side effects. Clinical studies showed
a more radiant, even toned and translucent skin appearance in just 7 days. Formulated to suit
all ages, elure’s gentle yet rich structure and active ingredients will reveal healthier, brighter and
younger looking skin.
elure™ Product Line
純正優雅。純潔之美。
elure嶄新凈白修護系列基於一個獨特的科學發現,採用純天然生物活性嫩白酵素
Melanozyme™分解黑色素。產品經臨床品質檢驗確保產品效果顯著,安全無副作用。
臨床證實,只需短短7天膚色頓時白晰平均,通透亮澤。配方適合所有年齡。elure的豐
郁質感和活性成份溫和地喚醒更明亮,更健康和更年輕的肌膚。
elure™ 淨白系列
Pure E
legance. Pure B
eauty.
Styl
Advanced Dermal Whitening
純正優雅。純潔之美。
嶄新淨白修護系列
Home About Us Technology Products Contact Us
elure’s Advanced Dermal Whitening skin products are all based on a unique scientific discovery of a naturally occurring bio-active substance, Melanozyme™, which acts to decompose the melanin in a clinically proven, fast and safe manner with no side effects. Clinical studies showed a more radiant, even toned and translucent skin appearance in just 7 days. Formulated to suit all ages, elure’s gentle yet rich structure and active ingredients will reveal healthier, brighter and younger looking skin.
the beauty of elure™
Pure E
legance. Pure
Tess Mauricio M.D.“
“As a Dermatologist, I believe elure represents a new paradigm in skin whitening. In our study
comparing elure with other available skin whitening products, I am
seeing faster, more dramatic results with no
irritation. My patients are amazed and excited by the results they are
seeing in as early as one week of use. They cannot wait to include
elure into their daily skin treatment regimen.
Tutenauer’s VisionFor over 80 years, Tuttnauer's sterilization and
infection control products have been trusted by
Hospitals, Universities, Research Institutes, Clinics
and Laboratories throughout the world. Supplying
a range of top-quality autoclaves, steam sterilizers,
washers and disinfectors to over 100 countries,
Tuttnauer has earned global recognition as a leader
in sterilization and infection control.
Your Sterilization & Infection Control PartnersTuttnauer
News & Events:
English Español Deutsch
Search
Tuttnauer USA WebsiteUS & Canadian Customers
Extranet Client Area
PharmaceuticalLaboratory
Dental &Private Clinics
Medical
ContactHome Products TechnologiesSupportsAbout Us
You foresee. They
NOTAL VISION™N
Foresee PHP™Open your eyes to better
AMD management
Foresee PHP™
FDA cleared
Long term monitoring of AMD
Rapid test time
Easy patient use
Automated analysis of test results – Locates
and quantifies AMD visual disturbance patterns
and provides rel iabi l i ty parameters
Call: 1-800-728-9615†or
e-mail [email protected]
distributed in the US byNOTAL VISION™NNotal Vision™ Ltd. Partners in Preserving Vision.
5 Droyanov St., Clal Building, Tel Aviv 63143 ISRAEL
Tel : +972-3- 629 -3763, Fax : +972-3- 6293764
in fo@nota lv i s ion .com, www.notalvision.com Not
al V
isio
n™ 2
006
copy
right
s re
serv
ed. 6
00D
038
Fore
see
PHP™
Pro
duct
Bro
chur
e
2|
Introducing a new standard for the early detection of CNV
The first FDA cleared diagnostic instrument indicated as an aid for the monitoring of AMDand detecting conversion to wet AMD
The Foresee PHP™ is a non-invasive visual field analyzer for monitoring Age-Related Macular
Degeneration (AMD) and detecting conversion to Choroidal Neovascularization (CNV or
wet AMD).
Clinically validated in numerous clinical trials, 1, 2, 3 the Foresee PHP™ technology provides an
unsurpassed level of sensitivity and specificity for early detection of CNV.
Excellent accuracy in early CNV detection – 82% sensitivity3
Your partner in preserving vision
Smarter, more effective AMD management
The Foresee PHP™ is the advanced, automated new version of the PHP. It allows frequent
monitoring of AMD patients while reducing technician time by up to 80%.
The new Foresee PHP™ also provides enhanced patient report tracking of the visual field changes
over time.
Earlier treatment means better clinical outcomes
With the new treatment options available today, it is essential to detect AMD progression as
soon as possible. Early detection results in early intervention that, in turn, results in better
patient visual outcomes.
Converting high-tech expertise into tools for advanced eye care
Notal Vision is positioned at the cutting edge of AMD diagnosis technology with a team of highly skilled
physicians, scientists, and professionals. Notal's technology enables physicians to detect the conversion from
dry to wet AMD, facilitating early intervention – the key factor in protecting patients from blindness caused
by the disease.
Despite recent advances in AMD therapeutics, most wet AMD patients have suffered irreversible vision loss
by the time they are first diagnosed with the disease. In most cases, current treatments may stop or slow
the progression of AMD but do not cure or reverse loss of vision.
Notal's advanced technology detects changes in the macular area of the patient’s retina at the earliest stages
of wet AMD, prior to vision loss.
Pioneering products that preserve vision
FDA cleared in the US, CE marked in Europe and approved in Japan, Notal Vision’s PHP is the first diagnostic
tool to meet the need for early detection of AMD, allowing eye care professionals to offer patients the highest
quality care and minimize damage caused by the disease.
Since its launch in 2004, the PHP has been sold to eye care professionals in the US and has gained a reputation
as an outstanding tool for the detection of the conversion of dry to wet AMD.
Foresee PHP™ is the second-generation PHP, now sold in the US through MSS (www.ms-services.com) and
worldwide through a chain of distributors. Foresee PHP™ features an automated diagnostic exam and continuous
monitoring of visual field changes.
Envisioning a brighter futureThrough close collaboration with scientific research clinicians and customers, and by sponsoring
ongoing clinical studies at leading medical centers, Notal Vision continues todevelop state-of-the-art products with improved detection capabilities,that reduce the threat of blindness.
Raising the standard for the early detection of AMD
Notal Vision designs and develops advanced non-invasive diagnostic solutions for the monitoring of AMD.
Working in collaboration with eye care researchers and professionals, Notal Vision provides solutions that
improve AMD diagnosis and management and set a new standard of eye care.
Notal Vision enjoys broad financial backing and dedicates more technical resources than any other company
in the field of diagnostics for the early detection of AMD. The company is headquartered in Tel Aviv, with
experienced management in both the US and Israel.
Top Related